Related Patent News
Competitive Technologies Announces Notice Of Allowance For Second Patent
Fairfield, CT. - Competitive Technologies, Inc (AMEX: CTT) today announced that the U.S. Patent Office has issued a Notice of Allowance for the U.S. Divisional Patent Application for CTT’s nanotechnology bone biomaterial developed at the University of South Carolina (“USC”). As a result, CTT expects that a second patent will be issued relating to this technology sometime this summer. CTT has an exclusive agreement with the University of South Carolina Research Foundation to license and commercialize this injectable, calcium phosphate-based biomaterial nanotechnology. The inventor of the bone biomaterial, Dr. Brian R. Genge, is a research professor in the Department of Chemistry and Biochemistry at USC. “The granting of this second patent recognizes the unique qualities of Dr. Genge’s innovative nanoparticle biomaterial technology,” said Dr. Mike Kiley, CTT’s Executive Vice President and Chief Technology Officer. “CTT executed an exclusive license in September 2005 with Soteira Inc.
Call Our Toll Free: (888) 275-2757 or Contact Us
Online For a No-Obligation Consultation
Bookmark: 
Permalink: http://S-0.ORG/V66tZwC
| Did You Know? |
|
A patent protects your invention.
A patent for an invention is a grant of property rights by the U.S. Government through the U.S. Patent and Trademark Office. The patent grant excludes others from making, using, or selling the invention in the United States. The terms "Patent Pending" and "Patent Applied For" are used to inform the public that an application for a patent has been filed. Patent protection does not start until the actual grant of a patent. Marking of an article as patented, when it is not, is illegal and subject to penalty.
|
Contact our Patent Professionals to ensure you complete the
patent filing process correctly or for violation of your patent rights.
|